Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech, LGC Forensics Ink Distribution Deal for Forensic DNA System

NEW YORK (GenomeWeb News) – Life Technologies today announced a distribution deal covering LGC Forensics' portable system for determining the quality of human DNA for forensics applications.

LGC's ParaDNA system facilitates the identification of samples that are suitable for more in-depth analysis by indicating whether samples contain usable DNA profiles. According to Life Tech, the ParaDNA platform is faster and more economical than other existing methods and helps reduce laboratory backlogs and processing turnaround times.

Carlsbad, Calif.-based Life Tech said that the deal with LGC is the second in a series of "Rapid DNA" products that the firm plans to introduce "to expand the landscape beyond traditional Rapid DNA systems." In September, Life Tech launched its GlobalFiler and GlobalFiler Express STR analysis kits for human identification and forensic applications.

The kits were the first to include all 24 STR loci commonly used in different combinations in the US, Europe, and other geographies for human identification, GenomeWeb Daily News sister publication PCR Insider reported at the time.

"We know that DNA profiling can help establish whether or not there is a link between a suspect and a crime," Mark Dearden, business unit director of ParaDNA for Teddington, UK-based LGC Forensics, said in a statement. "ParaDNA enables a quick and simple, on-the-spot, presumptive DNA screen to complement submissions policies — and could save significant time and cost in the investigative process."

Financial and other terms of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.